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Estudos fitoquímicos com as cascas do caule e com as folhas de Croton palanostigma Klotzsch 
(Euphorbiaceae) levaram ao isolamento do novo diterpeno clerodânico 8-epicordatina (2), além de 
éster metílico do ácido 12-oxohardwickiico (3), aparisthmano, cordatina (1), ácido ent-trachiloban-
18-óico, óxido de ent-13-epimanoila, óxido de ent-3-oxo-13-epimanoila, óxido de ent-3β-hidroxi-
13-epimanoila, sitosterol, estigmasterol, estigmastan-3-ona, 6β-hidroxiestigmast-4-en-3-ona, 
6E-hidroxiestigmasta-4,22-dien-3-ona, estigmast-4-en-3-ona, estigmasta-4,22-dien-3-ona, ácido 
3-O-acetilaleuritolico, 11D-hidroxiurs-12-en-3-ona, D-amirenona, 24-metilenocicloartenona 
e lupenona. Estas substâncias foram isoladas através de procedimentos fitoquímicos usuais e 
suas estruturas foram deduzidas por estudos espectroscópicos, incluindo experimentos em 2D. 
Adicionalmente, a estrutura cristalina de 8-epicordatina (2) foi determinada por difração de 
raios-X. Cálculos teóricos de RMN ao nível B3PW91/DGDZVP foram usados para confirmação 
dos assinalamentos dos deslocamentos químicos dos hidrogênios H-7D e H-7β de 8-epicordatina.
Phytochemical studies of the bark and leaves of Croton palanostigma Klotzsch (Euphorbiaceae) 
led to the isolation of a new clerodane diterpene, 8-epicordatin (2), in addition to 12-oxohardwickiic 
acid methyl ester (3), aparisthman, cordatin (1), ent-trachyloban-18-oic acid, ent-13-epimanoyl 
oxide, ent-3-oxo-13-epimanoyl oxide, ent-3E-hydroxy-13-epimanoyl oxide, sitosterol, stigmasterol, 
stigmastan-3-one, 6E-hydroxystigmast-4-en-3-one, 6E-hydroxystigmasta-4,22-dien-3-one, 
stigmast-4-en-3-one, stigmasta-4,22-dien-3-one, 3-O-acetylaleuritolic acid, 11D-hydroxyurs-12-
en-3-one, D-amyrenone, 24-methylenecycloartenone and lupenone. These compounds were isolated 
using typical phytochemical procedures and the structures were deduced from spectroscopic 
studies, including 2D NMR experiments. In addition, the crystalline structure of 8-epicordatin 
(2) was determined by X-ray diffraction. NMR theoretical calculations at the B3PW91/DGDZVP 
level were used to confirm the assignment of the chemical shifts of the H-7D and H-7E hydrogens 
of 8-epicordatin.
Keywords: Croton palanostigma Klotzsch, terpenes, steroids, NMR DFT calculations, X-ray 
crystallography
Introduction
Croton palanostigma Klotzsch (Euphorbiaceae) is 
a medium-sized tree native to the Northern Brazilian 
coastal region. Phytochemical studies of the bark of 
C. palanostigma under the erroneous identification of 
Aparisthmium cordatum1 yielded two furan diterpenes with 
a clerodane skeleton, namely, aparisthman2 and cordatin 
(1).3 These compounds showed anti-ulcer activity similar 
to that of cimetidine (Tagamet®), a compound used for the 
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treatment of peptic ulcers.4,5 This species, together with 
various Croton spp., is known to produce a red viscous 
sap called dragon’s blood. The sap of C. palanostigma is 
reported to have various pharmacological and physiological 
actions.6 Phytochemical studies of dragon’s blood obtained 
from Croton spp. led to the isolation of the alkaloid taspine,7 
the dihydrobenzofuran lignans 3´,4-O-dimethylcedrusin8 
and 4-O-methylcedrusin,9 and proanthocyanidins.10
The principal mechanism of the anti-ulcerogenic 
effect of cordatin (1) remains unknown. It seems to be 
related to an anti-secretory property, but the involvement 
of a mucosal defensive mechanism should not be 
ignored.5 Other anti-ulcerogenic drugs, such as the 
proton pump inhibitors omeprazole, lansoprazole and 
pantoprazole, exist as pro-drugs that need activation 
for interaction with gastric H+,K+-ATPase.11 Protonation 
of these compounds results in extensive molecular 
rearrangement followed by the formation of a positively 
charged sulfenamide species that has a low permeability 
coefficient across membranes and reacts covalently with 
free sulfhydryl group(s) on the extracellular surface of 
H+,K+-ATPase.12 The sulfonamide forms a disulfide that 
covalently modifies the enzyme’s extracellular domain 
and inhibits it with a stoichiometry of ~2 molecules of 
drug per subunit of H+,K+-ATPase.11
In the present work, a new phytochemical study of C. 
palanostigma was undertaken. The dichloromethane extract 
of the bark resulted in the new compound 8-epicordatin 
(2) (Figure 1). The hexane extract of the bark yielded 
12-oxohardwickiic acid methyl ester (3), together with 
other six diterpenoids, seven steroids and one triterpenoid. 
The hexane extract of the leaves yielded four triterpenoids. 
This study demonstrates the use of theoretical calculations 
in determining geometric parameters, chemical shifts and 
NMR coupling constants. The molecular electrostatic 
potential (MEP) was also calculated to define the most 
probable sites of interaction of 1 and 2 with H+ ions in 
gastric fluid.
Results and Discussion
The structures of the isolated compounds were deduced 
mainly from 1H and 13C NMR spectroscopic data at 300 
and 75.4 MHz, respectively, with the aid of 1H, 1H-COSY, 
13C,1H-COSY-1J (CH) and 13C, 1H-COSY-2;3J (CH) 
spectra. DEPT pulse sequences were used to determine 
the hydrogenation pattern of the carbons.
12-Oxohardwickiic acid methyl ester (3) was isolated 
as an oil. Its molecular formula is C21H28O4 (EIMS). Its IR 
spectrum is consistent with the presence of two conjugated 
carbonyl groups corresponding to peaks at 1668 (ketone 
adjacent to a furan ring) and 1714 cm-1 (ester adjacent to a 
double bond) and a furan ring (3135, 1509 and 872 cm-1).13 
Table 1 shows the 1H and 13C NMR spectroscopic data for 
3; these data are in complete agreement with those reported 
in the literature for 3, which was obtained by oxidation of 
12-hydroxyhardwickiic acid methyl ester, isolated from a 
hexane extract of the roots of Croton sonderianus.14 This 
compound (3) was isolated for the first time as a natural 
product from Croton polyandrous.15
The new natural product 8-epicordatin (2) was isolated 
as crystals. Its IR spectrum is consistent with the presence 
of an O–H group (3540 cm-1), two carbonyl groups 
corresponding to peaks at 1704 (δ-lactone) and 1733 cm-1 
(methyl ester) and a furan ring (3100, 1503 and 873 cm-1).13 
Its molecular formula is C21H26O6 (HRMS). This compound 
was identified by comparison of its NMR data (Table 1) 
with those reported in the literature for cordatin (1)3
,
 
crotobrasilin A16 and epi-cordatin.17 In addition, the NOESY 
data are similar to those reported in the literature used to 
propose the relative configurations at asymmetric centers 
for crotobrasilin A16 (Figure 2). Therefore, the new natural 
product 8-epicordatin (2) is the non-acetylated form of 
crotobrasilin A.16 Finally, the structure of 8-epicordatin 
(2) was also confirmed by X-ray diffraction. The ORTEP 
representation for the molecular labeling in the X-ray 
structure of 2 is shown in Figure 3. The most relevant X-ray 
Figure 1. Structures of 1, 2 and 3. Figure 2. Significant NOESY correlations of 2.
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and theoretical structural parameters for 2 are shown in 
Tables 2 and 3; complete data for the X-ray structure are 
shown in the supplementary material.
The configurations of the asymmetrical centers 
of aparisthman and cordatin (1) were determined by 
comparison of their NMR spectroscopic data with those 
obtained for authentic samples. Detailed NMR data for 1 
are presented in Table 1.
The known compounds were identified by comparison 
of their spectroscopic data with those reported in the 
literature. The 13C NMR spectral signals of ent-trachyloban-
18-oic acid at G 16.2 (Me-19) and 14.9 (Me-20) excluded 
the possible epimer ent-trachyloban-19-oic acid18 
[G 28.8 (Me-18) and 12.4 (Me-20)]. Furthermore, the 
configuration of ent-8D,13S to ent-3-oxo-13-epimanoyl 
oxide was confirmed by comparison of its optical rotation, 
Table 1. NMR spectroscopic dataa (300 and 75.4 MHz, CDCl3) for cordatin (1), 8-epicordatin (2) and 12-oxohardwickiic acid methyl ester (3)
Position Cordatin (1) 8-Epicordatin (2) 12-Oxohardwickiic acid methyl ester (3)
GC, mult. GH (J in Hz) GC, mult. GH (J in Hz) GC, mult. GH (J in Hz)
1 23.1, CH2 2.02, m 22.9, CH2 2.10, m 18.9, CH2
D, 1.52, ddd (1.3, 7.5, 13.5) 
E, 1.76, m
2 130.0, CH 5.93, ddd (2.7, 4.6, 10.1) 130.0, CH
5.95, ddd 
(2.9, 4.6, 10.0) 27.0, CH2
D, 2.15, m 
E, 2.07, ddd 
(3.3, 7.5, 11.4)
3 128.5, CH 5.31, dt (2.3, 10.1) 128.7, CH
5.36, ddd 
(1.8, 2.5, 10.0) 137.3, CH 6.56, dd (3.3, 4.5)
4 80.7, qC 81.2, qC 141.9, qC
5 40.6, qC 40.5, qC 37.9, qC
6 28.4, CH2
D, 1.54, dt (3.6, 13.4) 
E, 1.36, m 33.2, CH2
D, 1.86, dt (2.7, 13.3)
E, 0.91, td (3.0, 13.3) 35.3, CH2
D, 2.23, dt (3.0, 12.7) 
E, 1.12, m
7 17.7, CH2
D, 1.78, m 
E, 2.10, dq (3.6, 15.2) 18.1, CH2 a, 1.60, m b, 2.10, m 27.4, CH2 1.40, m
8 44.9, CH 2.48, dd (1.9, 3.6) 51.4, CH 2.07, m 37.3, CH 1.86, m
9 35.3, qC 36.4, qC 42.4, qC
10 44.7, CH 2.29, dd (5.6, 10.4) 44.7, CH 2.33, dd (5.2, 11.0) 47.1, CH 1.70, dd (1.3, 13.5)
11 48.9, CH2
D, 2.00, dd (1.8, 14.1) 
E, 1.78, m 44.4, CH2
D, 2.29, dd (5.4, 13.6)  
E, 1.67, dd (11.7, 13.6) 47.6, CH2
a, 2.70, d (14.8) 
b, 2.77, d (14.8)
12 69.8, CH 5.24 br, d (11.0) 71.9, CH 5.48, dd (5.4, 11.7) 194.9, qC
13 123.9, qC 125.8, qC 129.6, qC
14 108.5, CH 6.42, dd (0.9, 1.9) 108.5, CH 6.41, dd (0.9, 1.9) 108.9, CH 6.73, dd (0.8, 1.9)
15 143.6, CH 7.41, t (1.9) 143.7, CH 7.41, t (1.9) 144.1, CH 7.41, dd (1.4, 1.9)
16 139.6, CH 7.47 br, s 139.3, CH 7.44, m 146.7, CH 7.99, dd (0.8, 1.4)
17 173.8, qC 171.9, qC 16.6, CH3 0.90, d (6.8)
18 14.8, CH3 1.10, s 15.2, CH3 1.12, s 20.6, CH3 1.26, s
19 175.9, qC 175.5, qC 167.7, qC
20 24.4, CH3 1.32, s 15.4, CH3 1.17, s 17.6, CH3 0.84, s
21 53.4, CH3 3.78, s 53.2, CH3 3.81, s 51.0, CH3 3.66, s
a1H NMR referenced to CHCl3 at G 7.26 ppm; 1H, 1H-COSY spectra were used to determine spin-spin interactions.;13C NMR referenced to CHCl3 at 
G 77.00 ppm. All assignments were confirmed by 1H, 1H-COSY 13C, 1H-COSY-1JCH and 13C, 1H-COSY-2;3 JCH experiments.
Figure 3. ORTEP representation of 2.
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[D]2D5 –50.9° (CHCl3, c 0.11) and spectroscopic data to those 
reported in the literature.19 The same configuration was 
proposed for ent-13-epimanoyl oxide and ent-3E-hydroxy-
13-epimanoyl oxide.
The atomic distances, angles and torsion angles for 
both X-ray and B3LYP/6-31G(d,p) optimized structures 
of 2 presented in Table 3 are common for this type of 
compound. The hydroxyl group O6-H is involved in an 
intramolecular hydrogen bond with O5 at 2.128 Å (1.941 Å 
in calculations).
The crystallographic parameters for 2 were compared 
with data from the literature for 1,1,3 revealing similar 
structural parameters in the case of a trans relationship 
between the methyl group (C-20) attached to C-9 and the 
hydrogen borne by C-10, and the same type of relationship 
between the methyl group (C-18) attached to C-5 and the 
carbonyl carbon (C-19) linked to C-4. The cis relationship 
existing between the hydrogen on C-8 and the methyl 
group (C-20) located at C-9 in 11,3 is not present in 2. In 
this case, a trans relationship is observed. These results 
demonstrate that 2 has a trans-clerodane skeleton with a 
chair conformation for ring B and half-chair conformations 
for rings A and C due to the location of the double bond 
between C-2 and C-3 and the ester group at C-17.
Table 2. Crystallographic data for 2
Empirical formula C21 H26 O6
Molecular weight 374.42
Temperature 273(2) K
Wavelength 0.71073 Å
Crystal system Tetragonal
Space group P4(1)2(1)2
Unit cell dimensions a = 11.9617(5) Å, D= 90°
b = 11.9617(5) Å, E= 90°
c = 26.1728(15) Å, J= 90°
Volume 3744.9(3) Å3
Z 8
Density (calculated) 1.328 g/m3
Absorption coefficient 0.097 mm-1
F(000) 1600
Crystal size 0.50×0.36×0.29 mm3
T range for data collection 1.87-26.37°
Index ranges –10dhd10, 0dkd14, 0dld32
Reflections collected 3832
Independent reflections 3832 [R(int)=0.0000]
Completeness to T = 26.37° 100.0%
Absorption correction Semi-empirical from equivalents
Max. and min. transmission 0.9725 and 0.9532
Refinement method Full-matrix least-squares on F2
Data/restraints/parameters 3832/0/249
Goodness-of-fit of F2 1.015
Final R indices [I > 2sigma(I)] R1 = 0.0576, wR2 = 0.1489
R indices (all data) R1 = 0.0915, wR2 = 0.1775
Extinction coefficient 0.0063(13)
Largest diff. peak and hole 0.243 and –0.179 e Å–3
Table 3. Experimental and theoretical structural parameters for 2
Structural parameters Experimentala B3LYP/6-31G(d,p)
Bond distance (Å)
C4–C19 1.533(4) 1.553
C19–O5 1.205(3) 1.218
C19–O4 1.317(4) 1.338
O4–C21 1.437(3) 1.443
C4–O6 1.432(4) 1.421
C9–C20 1.536(4) 1.546
C5–C18 1.549(4) 1.548
C17–O2 1.214(5) 1.208
C12–C13 1.494(6) 1.498
Bond angle (°)
C4–C19–O5 123.6(3) 121.7
C4–C19–O4 113.4(2) 115.2
O5–C19–O4 123.0(3) 123.1
C19–O4–C21 117.5(2) 115.5
C3–C4–O6 106.5(3) 108.1
C10–C9–C20 114.2(2) 113.9
C8–C17–O2 123.5(6) 123.5
C20–C9–C11 109.8(3) 109.1
C11–C12–C13 112.5(3) 112.8
C4–C5–C18 107.1(3) 106.3
O1–C12–C13 106.6(3) 107.3
Dihedral angles (°)
C5–C4–C19–O4 75.1 74.7
C5–C4–C19–O5 –105.4 –106.2
C4–C19–O4–C21 178.8 179.5
C6–C7–C8–C17 171.0 168.5
O5–C19–O4–C21 –0.7 0.4
C20–C9–C8–C17 56.0 60.5
C20–C9–C11–C12 –60.5 –58.7
C9–C11–C12–C13 –154.9 –165.9
C11–C12–C13–C16 –88.2 –111.1
C11–C12–C13–C14 86.8 67.1
O1–C12–C13–C14 –40.1 –58.9
O1–C12–C13–C16 144.9 122.9
aEstimated standard deviation in parentheses.
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The 1H and 13C NMR spectra were calculated for 2 and 
TMS (internal standard) (shielding constants of 32.1843 to 
1H and 186.3296 to 13C). Calculated and experimental 1H and 
13C NMR chemical shifts, as well as theoretical, predicted and 
experimental results for the coupling constants [nJ (H-H)] 
of 2 are presented in the supplementary material. The most 
relevant statistical parameters are presented in Table 4. 
Figure 4 shows the correlation between calculated and 
experimental 1H chemical shifts (A), 13C chemical shifts 
(B) and coupling constants (C). Statistical analysis revealed 
good correlation for the model of 1H and 13C chemical 
shifts (R2 = 99.41%, F = 2703.85, s = 0.19, Q2 = 99.26% 
for 1H and R2 = 99.89%, F = 18054.82, s = 1.84, Q2 = 99.86% 
for 13C) (Figure 4 A and B). Calculations for the coupling 
constant yielded slightly worse results compared to 
those for the chemical shifts (Figure 4 C) (R2 = 94.68%, 
F = 289.42, s = 1.22, Q2 = 92.80%), but they are considered 
satisfactory. These results confirm the relevance of the 
theoretical data used to confirm chemical shifts for the 
hydrogens H-7D (1.60 experimental and 1.55 predicted) and 
H-7E (2.10 experimental and 2.32 predicted) because the 
NMR experiments performed did not allow this definition.
In Figure 4B, we can see that the general correlation to 
statistical analysis of 13C NMR parameters is satisfactory, 
because all signals originating from different functional 
groups fall into their own distinctive regions. Thus, the 
overall reliability of this calculation is borne out. However 
some signals appear in reverse order than they would in the 
experimental spectrum. We note that these inversions do 
occur, nevertheless, only for closely spaced points, hence 
presumably originating from nuclei in the same functional 
group. The order is correct for 17 (out of 21) 13C NMR 
signals, but two pairs are interchanged with respect to 
the experimental ordering: C-2, C-3 (theoretical = 137.6 
and 139.5 ppm; experimental = 130.0 and 128.7 ppm, 
respectively) and C-10, C-11(theoretical = 50.1 and 
51.3 ppm; experimental = 44.7 and 44.4 ppm, respectively).
Despite the significant results in the statistical analysis, 
the individual differences between experimental and 
theoretical 13C NMR data are considerably high. For 
example, there are chemical shifts of some sp2 carbons 
in which the theoretical and experimental chemical shifts 
differ by more than 8 ppm (for C-3 the residue is 10.8 ppm, 
for C-19 the residue is 12.2 ppm).
Recently, we successfully used three-dimensional MEP 
surfaces to define the most probable sites of protonation of 
dipyridamole and on the study of the molecular mechanisms 
Figure 4. Correlation between calculated (B3PW91/DGDZVP) and 
experimental 1H (A) 13C (B) NMR chemical shifts and coupling constant 
[nJ(H–H)] (C) of 2.
Table 4. Correlation and fitting parameters for calculated NMR properties 
of 2a
A b R2 F s Q2
G (1H) –0.17 1.03 99.41% 2703.85 0.19 99.26%
G (13C) 3.91 1.03 99.89% 18054.82 1.84 99.86%
nJ(H–H) 0.05 1.08 94.68% 289.42 1.22 92.80%
aLinear fitting parameters refer to G
calcd = a+bGexptl. For coupling constants 
replace G with J.
Isolation, X-ray Crystal Structure and Theoretical Calculations J. Braz. Chem. Soc.736
the Diels-Alder reaction.20 The MEP surfaces of 1 and 2 
(Figure 5) in terms of total electron density show that the 
lowest electronic potential is in the proximity of oxygen 
atoms of the lactone (O1, O2), the hydroxyl group (O6) 
and the carbonyl group of ester (O5). The large negative 
potential of oxygen atoms may be regarded as a nucleophilic 
suction pump,21 acting as a possible magnet for electrophilic 
attack of H+ or part of a biological receptor. The surfaces 
of 1 and 2 are visually similar, suggesting that 2 may have 
anti-ulcer activity similar to that of 1. Experimental studies 
are being conducted to prove this hypothesis for 2.
 
Experimental
General Experimental Procedures
IR spectra were recorded on NaCl for compound 3 and 
using the pure substance for compound 2. 1H and 13C NMR 
data were obtained at 300 and 75.4 MHz, respectively, in 
CDCl3 using the solvent peak as the internal standard. EIMS 
spectra were obtained at 70 eV (probe) for compound 3 
and HREI-MS data were obtained for compound 2. TLC 
was on silica gel 60H (Merck 7736) and CC on silica gel 
(Merck 7734).
Plant Material
Croton palanostigma Klotzsch (Euphorbiaceae) was 
collected in March 2007 in Terra Alta, Pará, Brazil. A 
voucher specimen was identified by Dr. Ricardo Secco and 
is deposited in the herbarium of Museu Paraense Emílio 
Goeldi, Belém, Pará, Brazil (MG 182.822).
Extraction and isolation
Dried and powdered bark (740 g) and leaves (590 g) of 
C. palanostigma were successively extracted in a Soxhlet 
apparatus using hexane, CH2Cl2 and MeOH. During 
concentration of the hexane bark extract, a white solid 
(1.5 g) composed mainly of aparisthman and cordatin 
(1) (1:1) precipitated. The remaining hexane bark extract 
was concentrated under vacuum to yield a gum (20.5 g). 
The gum was subjected to CC and TLC on silica gel 
and eluted with mixtures of hexane, EtOAc and MeOH 
in increasing order of polarity, yielding aparisthman2 
(800 mg), 13 (60 mg), 314 (7 mg), ent-trachyloban-
18-oic acid22 (217 mg), ent-13-epimanoyl oxide19 
(40 mg), ent-3-oxo-13-epimanoyl oxide19 (18 mg) ent-
3E-hydroxy-13-epimanoyl oxide19 + 3-O-acetylaleuritolic 
acid23 (6 mg), sitosterol24,25 + stigmasterol25 (13 mg), 
stigmastan-3-one26 (5 mg), 6E-hydroxystigmast-4-en-3-
one27 + 6E-hydroxystigmasta-4,22-dien-3-one28 (41 mg), 
stigmast-4-en-3-one27 + stigmasta-4,22-dien-3-one29 
(13 mg) and 3-O-acetylaleuritolic acid23 (127 mg). The 
dichloromethane bark extract was concentrated under 
vacuum to yield a gum (5.1 g). The gum was subjected 
to CC and TLC and eluted with mixtures of hexane, 
EtOAc and MeOH in increasing order of polarity, yielding 
13 (270 mg) and the new compound 8-epicordatin (2) 
(20 mg). The hexane leaf extract was concentrated under 
vacuum to yield a gum (2.6 g). The gum was subjected to 
CC and TLC and eluted with hexane, EtOAc and MeOH 
in increasing order of polarity, yielding D-amyrenone30 + 
24-methylenecycloartenone31 + lupenone30,32 (31 mg) and 
11D-hydroxyurs-12-en-3-one33 (10 mg).
Crystallography
A single crystal of 2 was mounted on glass fiber 
in random orientation. Data collection was performed 
at room temperature using a Siemens Smart CCD 
diffractometer with graphite-monochromated Mo-KD 
radiation (O= 0.71073 $) with a nominal crystal detection 
distance of 4.0 cm. A hemisphere of data was collected 
based on three Z-scans (starting Z= –28°) at values of 
I= 0°, 90° and 180° with the detector at 2T = 28°. For each 
of these runs, frames (606, 435 and 230, respectively) were 
collected at 0.3° intervals using 30 s per frame.
The diffraction frames were integrated using the SAINT 
package34 and corrected for absorption using SADABS.35
Table 2 shows a summary of data collection and 
refinement conditions for the crystal structure.
Computational Methods
Since it was difficult to define chemical shifts for 
hydrogens H-7D and H-7E, theoretical NMR calculations 
at the B3PW91/DGDZVP level were used to confirm 
the assignments. Similar methods involving comparison 
of experimental and theoretical NMR data have been 
reported for aparisthman,36 strychnine,37 corianlactone,37 
Figure 5. Three-dimensional MEP surfaces for 1 (A) and 2 (B).
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daphnipaxinin,37 boletunone B,37 julocrotine,38 cordatin1 
and others.
The geometry obtained from X-ray diffraction data of 
2 was used as input for the full geometry optimization. 
This molecular conformation was optimized using the 
B3LYP hybrid functional,39 together with the 6-31G(d,p) 
basis in the Gaussian 03 molecular package.40 Vibrational 
analysis was carried out for the complete equilibrium 
geometry obtained by the procedure in the Gaussian 03 
package at the DFT level with the B3LYP/6-31G(d,p) level 
in the gas phase, ensuring that each gradient optimization 
located was indeed a true minimum energy structure (no 
imaginary frequencies). Normal modes were analyzed 
visually using Hyperchem 7.5.41 NMR (1H and 13C chemical 
shifts and coupling constants) spectra were calculated 
by the B3PW91/DGDZVP method in the gas phase for 
the geometry optimized using the B3LYP/6-31G(d,p) 
method. The use of a method for geometry optimization 
(B3LYP/6-31G(d,p) ) and another one for NMR calculation 
has been successfully used by Bagno et al. (2006)37 to 
predict NMR data of several natural products. Recently, 
we have successfully used this methodology to study 1H 
and 13C NMR spectra of cordatin.1 In this case the geometry 
obtained was similar to that observed by X-Ray diffraction 
and could be used in calculations of NMR proprieties. All 
calculations were performed using Gaussian 03.40 Linear 
regression analysis of NMR data was performed and 
relevant parameters were selected: correlation coefficients 
(R2), Fisher ratio values (F), the standard deviation (s) and 
the predictive ability of the model (Q2). MINITAB® release 
14 was used for statistical analysis.42
The MEP surface was generated using HF/6-31G(d,p) 
with the geometry optimized in B3LYP/6-31G(d,p) and 
an isopotential of –20.0 a.u. On the MEP surface, regions 
indicating excess negative potential correspond to excess 
negative charges, i.e., attraction of the positively charged 
probe. The MEP surface was calculated and analyzed 
visually using the PC Spartan PRO molecular package.43
8-Epicordatin (2)
Crystals; Dec. 174-176 °C; [D]2D5 +107.35° (c 0.19, 
CHCl3); IR Qmax/cm-1: 3540, 3100, 2947, 1733, 1704, 1503, 
1429, 1367, 1246, 1132, 1089, 873; 1H NMR: see Table 1 
and 13C NMR: see Table 1; HRMS m/z [M+Na]+ 397.1635 
(calc. for C21H26O6+Na, 397.1627); X-ray crystallography 
data: see Table 3 and Figure 3.
12-Oxohardwickiic acid methyl ester (3)
Oil. [D]2D5 –24.07° (c 0.054, CHCl3); IR Qmax/cm-1: 3135, 
1714, 1668, 1509, 1461, 1250, 1232, 1157, 872; 1H NMR: 
see Table 1 and 13C NMR: see Table 1; EIMS m/z (rel. int.): 
344 [M]+ (0.3), 313 [M–OMe]+ (2.6), 284 [M–HCO2Me]+ 
(0.5), 236 (10.0), 235 (57.3), 234 [M–CH2=C-furyl]+ (19.8), 
233 (5.3), 220 (21.2), 219 [234–Me]+ (100), 218 (13.7), 217 
(7.0), 187 (15.7), 175 (3.1), 105 (4.0), 95 (10.5).
Conclusions
The chemical study of the bark and leaves of Croton 
palanostigma Klotzsch (Euphorbiaceae) led to the isolation 
of a new clerodane diterpene, 8-epicordatin. X-ray diffraction, 
NMR experiments and theoretical calculations were used to 
propose the structure of this compound. The calculated 
geometric parameters are close to the X-ray crystal structure 
indicating the accuracy of theoretical method used. The NMR 
theoretical values show good correlation and high predictive 
power and could be used to confirm the chemical shifts of 
hydrogens H-7D and H-7E. Therefore, DFT calculations can 
attain a considerable degree of accuracy in the prediction of 
the 13C and 1H NMR spectra of complex organic molecules 
such as natural products. The MEP surfaces of cordatin and 
8-epicordatin shows four sites susceptible of protonation 
(O1, O2, O5 and O6 positions) indicating that these species 
might, consequently, interact with the extracellular surface 
of the H+, K+-ATPase.
Supplementary Information
Crystallographic data for the structure reported in 
this paper have been deposited with the Cambridge 
Crystallographic Data Centre, number CCDC 666036. 
Copies of the data can be obtained, free of charge, on 
application to the Director, CCDC, 12 Union Road, 
Cambridge CB2 1EZ, UK (fax: +44-1223-336033 or 
e-mail: deposit@ccdc.cam.ac.uk). 
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